Interactions between Microbiome and DME (MICBIO)
|
Bacteria: Actinobacteria |
Streptomyces griseus (actinobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Streptomyces griseus co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
Bacteria: Chlamydiae |
Chlamydia muridarum (chlamydias) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Chlamydia muridarum co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4], [5] |
Bacteria: Firmicutes |
Faecalibacterium prausnitzii (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Faecalibacterium prausnitzii co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [6] |
Lactobacillus casei (firmicutes) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Lactobacillus casei co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [7], [8] |
Bacteria: Proteobacteria |
Escherichia coli (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 2 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Escherichia coli co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
Folic acid |
Click to Show/Hide the Detail |
Drug ID |
DR0742
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Escherichia coli co-metabolize the drug Folic acid, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [10], [11] |
Klebsiella pneumoniae (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Klebsiella pneumoniae co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
Raoultella planticola (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Doxorubicin |
Click to Show/Hide the Detail |
Drug ID |
DR0546
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Raoultella planticola co-metabolize the drug Doxorubicin, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [9] |
Salmonella enterica (enterobacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
Menadione |
Click to Show/Hide the Detail |
Drug ID |
DR1022
Drug Info
|
Interaction Mechanism |
Human Methionine synthase reductase (MTRR) and Salmonella enterica co-metabolize the drug Menadione, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [12], [13] |
|
|
|
|
|
|